Glucose‐6‐phosphate dehydrogenase, NADPH, and cell survival
Tóm tắt
Glucose‐6‐phosphate dehydrogenase (G6PD) is the rate‐limiting enzyme of the pentose phosphate pathway. Many scientists think that the roles and regulation of G6PD in physiology and pathophysiology have been well established as the enzyme was first identified 80 years ago. And that G6PD has been extensively studied especially with respect to G6PD deficiency and its association with hemolysis, and with respect to the role G6PD plays in lipid metabolism. But there has been a growing understanding of the central importance of G6PD to cellular physiology as it is a major source of NADPH that is required by many essential cellular systems including the antioxidant pathways, nitric oxide synthase, NADPH oxidase, cytochrome p450 system, and others. Indeed G6PD is essential for cell survival. It has also become evident that G6PD is highly regulated by many signals that affect transcription, post‐translation, intracellular location, and interactions with other protein. Pathophysiologic roles for G6PD have also been identified in such disease processes as diabetes, aldosterone‐induced endothelial dysfunction, cancer, and others. It is now clear that G6PD is under complex regulatory control and of central importance to many cellular processes. In this review the biochemistry, regulatory signals, physiologic roles, and pathophysiologic roles for G6PD that have been elucidated over the past 20 years are discussed. 2012 IUBMB IUBMB Life, 2012
Từ khóa
Tài liệu tham khảo
Ho H. Y., 2005, G6PD—an old bottle with new wine, Chang Gung Med. J., 28, 606
Tian W. N., 1994, Signal transduction proteins that associate with the platelet‐derived growth factor (PDGF) receptor mediate the PDGF‐induced release of glucose‐6‐phosphate dehydrogenase from permeabilized cells, J. Biol. Chem., 269, 14798, 10.1016/S0021-9258(17)36695-4
Costa Rosa L. F., 1995, Effect of adrenaline and phorbol myristate acetate or bacterial lipopolysaccharide on stimulation of pathways of macrophage glucose, glutamine and O2 metabolism. Evidence for cyclic AMP‐dependent protein kinase mediated inhibition of glucose‐6‐phosphate dehydrogenase and activation of NADP+‐dependent ‘malic’ enzyme, Biochem. J., 310, 709, 10.1042/bj3100709
Niazi G. A., 1991, Glucose‐6‐phosphate dehydrogenase deficiency and diabetes mellitus, Int. J. Hematol., 54, 295
Gaskin R. S., 2001, G6PD deficiency: its role in the high prevalence of hypertension and diabetes mellitus, Ethn. Dis., 11, 749